
Successful PRE-APPROVAL INSPECTION FOr uip
THE UNIVERSITY OF IOWA PHARMACEUTICALS PASSED A PRE-APPROVAL INSPECTION FOR AN ASEPTICALLY FILLED STERILE DRUG PRODUCT.
On August 27, 2009, the Kansas City District Office of the Food and Drug Administration (FDA) submitted a recommendation of approval to the Center for Drug Evaluation and Research for The University of Iowa Pharmaceuticals (UIP) to manufacture an aseptically filled sterile drug product for a commercial client. The drug product contains a new chemical entity and is a sterile solution that is aseptically filled into a vial. This recommendation came after an FDA Pre-Approval Inspection (PAI) of UIP’s facilities and procedures and review of the product’s manufacturing and testing procedures described in the product’s NDA. The inspection covered general GMPs as well as specific information related to the manufacture and analytical testing of the product. This FDA approval represents the second approval for UIP to provide manufacturing and/or testing services to a client in support of a commercial product this year. UIP looks forward to continuing to work with client organizations to support their formulation development, clinical trial and commercial product manufacturing and testing needs.
For a limited time: UIP is offering special pricing on lyophilization cycle development services. Read More...
September 2009: UIP has completed installation of a Lyotherm 2 and Lyostat 2 for use in lyophilization cycle development. Read More...
August 2009: UIP has completed qualification of a new Flexicon FP50 Aseptic Filling and Stoppering Machine for use in our Clean Room that serves our Hull 48 square foot lyophilizer in the Sterile Products department. Read More...
July 2009: Renovation of an additional approximately 1,000 square feet of newly acquired space in UIP’ building at the Oakdale Research Park nears completion. Read More...
June-July 2009: In a letter dated June 15th from the Kansas City District Office of the FDA, UIP received notice that based on the results of our most recent GMP inspection (March and April of 2009) the Kansas City District has recommended that a client’s ANDA is approvable. Read More...
June 2009: UIP purchased a Minncare Dry Fog System which is
currently being qualified for use in the Sterile Products department. Read More...
Please call or send an e-mail to discuss project needs, schedule a visit and tour, or audit our facilities and procedures. For more information please contact either of the following contacts:
Mickey L. Wells, Ph.D.,
Director
E-mail: mickey-wells@uiowa.edu
Randy R. Yeates, R. Ph., M.B.A.,
Asst. Dir. Business Development
E-mail: randhall-yeates@uiowa.edu
The University of Iowa Pharmaceuticals
College of Pharmacy
115 South Grand Avenue, G-20
Iowa City, Iowa 52242
Phone: (319) 335-8674
Fax: (319) 335-9418